Clinical Trial

EMLA Cream as Analgesic for Outpatient Gynecological Procedures

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare pain perception in the study participant population undergoing the following gynecological procedures: Intra Uterine Device (IUD) insertion, hysteroscopy, and endometrial biopsy and given either Eutectic Mixture of Local Anesthetics (EMLA) cream or a placebo. The main question to answer is: • Does EMLA cream reduce pain when administered during the following gynecological procedures: IUD insertion, hysteroscopy, and endometrial biopsy? Participants will be asked to do assess their pain on the Visual Analogue Scale through 3 times during the procedure. Researchers will compare the study group with those receiving placebo group to see if there is a difference in pain scores.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT05970354
Lead Sponsor CAMC Health System
Conditions Pain
Enrollment 400 participants
Start Date 2023-09-15
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-08-01